The Measles (& Rubella) Initiative

In recent years, the field of global health has moved away from disease-specific approaches, like the Measles initiative, as health system approaches are favored.  At the same time, U.S. measles cases are on the rise even in our 92Y neighborhood where a health system is long established and fairly accessible.  Weak health systems prevent measles from being eradicated, so health system strengthening is a crucial long-term goal.  But without organizations with targeted short-term goals, regression in public health outcomes is possible, as evidenced by the reappearance of measles in the U.S.

In a Google search for the Measles Initiative’s website, I was surprised to discover that since the Global Health Delivery’s 2011 Case Study on the Measles Initiative, the organization broadened its name, and mission, to the Measles & Rubella Initiative.  The organization partners with countries to immunize and monitor outbreaks through planning, monitoring, and implementing campaigns.  In its 13-year mission, the M&R Initiative reduced measles deaths by 74% from 2000-2007 and by 78% from 2000-2012.  There are still 122,000 measles deaths annually, and the disease accounts for 4% of all child mortalities.

There is still a gap between today’s 78% reduction and the proposed 90% reduction, or even eradication hoped for by 2010.  There are many challenges associated with eliminating Measles: there is no cure, it is highly contagious, and immunity often requires two vaccinations.  The slow progress achieved by the M&R Initiative is not insignificant in light of these challenges.  The widening of the organization to encompass Rubella appears to be an effort to maintain its crucial role in mitigating these specific diseases, while addressing the larger health care issue of ensuring regular vaccination.